Drug Trial Radar · NCT07114874
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Last checked: Nov 20, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
600
Planned (sponsor's estimate)
Start
Jul 11, 2025
Primary completion
Dec 2031
Study completion Dec 2031
Sponsor
- Lead sponsor
- Neurocrine BiosciencesNeurocrine Biosciences (NBIX)
- Sponsor type
- Industry
- First posted
- Aug 11, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the long-term safety of NBI-1117568 in adults with schizophrenia.
Conditions
- Schizophrenia
Interventions
NBI-1117568Drug
NBI-1117568 will be administered per schedule specified in the arm description.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants with Treatment-emergent Adverse EventsTime frame: Up to 36 months
Locations
61 sites in 5 countries. Site status is shown where the registry gives one.
Neurocrine Clinical Site
Bryant, Arkansas · Recruiting
Neurocrine Clinical Site
Little Rock, Arkansas · Recruiting
Neurocrine Clinical Site
Cerritos, California · Recruiting
Neurocrine Clinical Site
Chino, California · Recruiting
Neurocrine Clinical Site
Culver City, California · Recruiting
Neurocrine Clinical Site
Garden Grove, California · Recruiting
Neurocrine Clinical Site
La Habra, California · Recruiting
Neurocrine Clinical Site
Lemon Grove, California · Recruiting
Neurocrine Clinical Site
Oceanside, California · Recruiting
Neurocrine Clinical Site
Pico Rivera, California · Recruiting
Neurocrine Clinical Site
Riverside, California · Recruiting
Neurocrine Clinical Site
San Diego, California · Recruiting
Neurocrine Clinical Site
Sherman, California · Recruiting
Neurocrine Clinical Site
Torrance, California · Recruiting
Neurocrine Clinical Site
West Hills, California · Completed
Neurocrine Clinical Site
Atlantis, Florida · Recruiting
Neurocrine Clinical Site
Aventura, Florida · Recruiting
Neurocrine Clinical Site
Doral, Florida · Withdrawn
Neurocrine Clinical Site
Hollywood, Florida · Recruiting
Neurocrine Clinical Site
Maitland, Florida · Recruiting
Neurocrine Clinical Site
Miami, Florida · Recruiting
Neurocrine Clinical Site
Miami, Florida · Withdrawn
Neurocrine Clinical Site
Miami Lakes, Florida · Recruiting
Neurocrine Clinical Site
Tampa, Florida · Recruiting
Neurocrine Clinical Site
West Palm Beach, Florida · Recruiting
Neurocrine Clinical Site
Atlanta, Georgia · Recruiting
Neurocrine Clinical Site
Atlanta, Georgia · Recruiting
Neurocrine Clinical Site
Decatur, Georgia · Recruiting
Neurocrine Clinical Sites
Peachtree Corners, Georgia · Recruiting
Neurocrine Clinical Site
Chicago, Illinois · Recruiting
Neurocrine Clinical Site
Oak Brook, Illinois · Recruiting
Neurocrine Clinical Site
Gaithersburg, Maryland · Recruiting
Neurocrine Clinical Site
Boston, Massachusetts · Recruiting
Neurocrine Clinical Site
Watertown, Massachusetts · Recruiting
Neurocrine Clinical Site
Flowood, Mississippi · Recruiting
Neurocrine Clinical Site
St Louis, Missouri · Recruiting
Neurocrine Clinical Site
Marlton, New Jersey · Recruiting
Neurocrine Clinical Site
Cedarhurst, New York · Recruiting
Neurocrine Clinical Site
New York, New York · Recruiting
Neurocrine Clinical Site
New York, New York · Recruiting
Showing 40 of 61 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.